Inmune Bio, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2021

Taxonomy & unit: us-gaap: USD
Description: The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary: Inmune Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2021.
Inmune Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $193K.
Inmune Bio, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.19M, a 1020% decline from 2020.

Nonoperating Income (Expense), Trailing 12 Months (USD)

Nonoperating Income (Expense), Annual (USD)

Nonoperating Income (Expense), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2021	-$1.19M	-$1.32M	-1020%	Jan 1, 2021	Dec 31, 2021	10-K	2022-03-03
2020	$129K			Jan 1, 2020	Dec 31, 2020	10-K	2022-03-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.